COPD Clinical Trials in Baltimore, MD

21 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	Phase 3	AstraZeneca	<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)	Phase 3	AstraZeneca	<1 mi
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.	Phase 4	Sanofi	<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)	—	University of Massachusetts, Worcester	<1 mi
Trial to Determine Effective Aspirin Dose in COPD	Phase 3	Johns Hopkins University	<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Phase 2	Johns Hopkins University	<1 mi
Multi-Center Clean Air Randomized Controlled Trial in COPD	Phase 3	JHSPH Center for Clinical Trials	<1 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease	Phase 2	AstraZeneca	<1 mi
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home	N/A	Temple University	<1 mi
OMEGA - Dietary Intervention - COPD Trial	N/A	Johns Hopkins University	<1 mi
Effectiveness of the WearME System for COPD Severity and Respiratory Function	—	LASARRUS Clinic and Research Center	<1 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening	—	Freenome Holdings Inc.	<1 mi
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease	Phase 3	AstraZeneca	9 mi
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD	Phase 2	Altesa Biosciences, Inc.	9 mi
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)	Phase 3	GlaxoSmithKline	32 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD	Phase 2	Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA	32 mi
COPD Patient-Powered Research Network	—	COPD Foundation	36 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	36 mi
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3	N/A	Apreo Health, Inc.	41 mi
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	N/A	Pulmonx Corporation	41 mi
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment	Phase 2	Expedition Therapeutics, Inc	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.